Congenital Diaphragmatic Hernia
1
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
KARL STORZ EndoscopyCA - El Segundo
2 programs11540KE and Balt Goldbal 2 balloonN/A1 trial
Fetal Treatment ArmN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
City TherapeuticsRepair of CDH w/SIS Gold
KARL STORZ EndoscopyFetal Treatment Arm
KARL STORZ Endoscopy11540KE and Balt Goldbal 2 balloon
Clinical Trials (3)
Type of Material in Repair of Congenital Diaphragmatic Hernia
Start: Dec 2005Est. completion: Aug 2007
Phase 3Terminated
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
Start: Jun 2025Est. completion: Dec 2031
N/ARecruiting
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
Start: Aug 2015Est. completion: Mar 2028
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
2 companies competing in this space